Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)Release Date:Quality Improvement Oncology Canada Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in ChinaRelease Date:Research Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Title Grant Type Focus Area Country Application Due Date Optimizing Androgen Deprivation Therapy (ADT) in Advanced Prostate CancerEducation Oncology USA Optimizing Biomarker-Directed Therapy in Metastatic Colorectal CancerRelease Date:Partner: The National Comprehensive Cancer Network®, Fight Colorectal CancerQuality Improvement Oncology USA Addressing the Needs of Patients with Mental Health Issues and Dermatological Inflammatory ConditionsRelease Date:Quality Improvement Inflammation & Immunology Canada Quality Improvement Grants to Improve Identification and Management of Patients with ATTR-CMRelease Date:Quality Improvement Rare Disease Canada Transthyretin Amyloid Cardiomyopathy (ATTR-CM) ResearchRelease Date:Research Rare Disease USA Improving Treatment Environment and Survivorship for Multiple MyelomaRelease Date:Education Oncology Japan Improving Treatment Environment and Survivorship for LeukemiaRelease Date:Education Oncology Japan Advances in the Management of Ulcerative Colitis (UC) (Europe, Canada, Japan, South Korea, Australia, New Zealand, Israel)Release Date:Education Inflammation & Immunology All Increasing Awareness and Understanding of Transthyretin Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Shared Decision-Making (SDM) for Patient Quality of Life in Cancer Treatment and Improving Access to BiologicsRelease Date:Education Oncology Japan Improvement of Treatment Environment of Immuno-Oncology Therapy for Urothelial CancerRelease Date:Quality Improvement Oncology Japan Optimizing the management of mBC HER2-patients / OncologyRelease Date:Quality Improvement Oncology Italy